Skip to main
  1. Stocks
  2. Tenet Healthcare
  3. Forecast
THC

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 53%
Hold 13%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare is supported by stronger core execution, with revised FY26 adjusted EBITDA estimates of about $5.13B to $5.14B and guidance of $5.05B-$5.20B, reflecting 12%-15% core EBITDA growth driven by growth and cost efficiencies. Its bullish case is anchored in USPI’s higher-margin ambulatory surgery center platform, which generated $537M of adjusted EBITDA with 9% year-over-year growth, 4.5% same-facility revenue growth, and 12.8% same-store joint replacement growth, alongside hospital adjusted admissions growth of 3.2% and sustained expense discipline. Management’s diversified mix, improving financial flexibility, stabilized uncompensated care trends, and benefits from the Conifer transaction and ongoing portfolio rationalization support the view that Tenet can sustain margin expansion and outperform peers despite reimbursement headwinds.

Bears say

Tenet Healthcare is facing a negative outlook because the downside case assumes professional fees and elevated labor costs stay higher than expected next year, pressuring margins and reducing operating leverage across its hospital and outpatient footprint. Under that scenario, EBITDA falls 10% below the base estimate, implying that even modest cost persistence could materially weaken earnings power and investor confidence in the core business and the Conifer revenue cycle management segment. With valuation compressed to about 8.0x, the analysis signals that the stock’s fundamentals remain vulnerable to cost inflation and multiple contraction if execution does not improve.

Tenet Healthcare (THC) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 53% recommend Buy, 13% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Tenet Healthcare (THC) Analyst Forecast & Price Prediction

Get the latest Tenet Healthcare (THC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Tenet Healthcare (THC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 15 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $290.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $290.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Tenet Healthcare (THC) Analyst Forecast & Price Prediction

Get the latest Tenet Healthcare (THC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Tenet Healthcare (THC)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover THC stock data and trends